Follow us on:

Linkedin Facebook

FTSE 100

FTSE 100 Market news covers the latest developments for the FTSE 100 Index, which tracks the 100 most highly capitalised blue‑chip companies listed on the London Stock Exchange.

This category includes updates on company admissions and delistings, quarterly and annual results, mergers and acquisitions, board appointments and departures, regulatory news and policy changes.

Severn Trent

Severn Trent on track for environmental targets and record capital investment year

Severn Trent Plc says trading for the period to 10 February 2026 is in line with expectations, with strong operational momentum and capital investment expected at the top end of its £1.7–£1.9 billion guidance...
BT Group Plc

BT Group confirms CEO changes across Openreach and BT International

From 1 April 2026, Katie Milligan will assume the role of CEO of Openreach, with Clive Selley moving to lead BT International...
AstraZeneca

AstraZeneca Q4 and FY 2025: Strong sales growth and pipeline momentum

Excerpt In FY 2025, AstraZeneca achieved 9% reported revenue growth and a 45% increase in reported EPS, reflecting strong commercial execution and pipeline progress...
Coca Cola

Coca-Cola HBC AG reports strong 2025 results with 8.1% organic revenue growth

Coca-Cola HBC AG delivered strong growth in 2025, with organic revenue up 8.1% and organic EBIT up 11.5%, driven by volume growth in Sparkling and Energy, disciplined revenue growth management, and continued investment in digital and AI capabilities...

Barclays reports double-digit returns across all divisions in 2025

Barclays PLC delivered a strong financial performance in 2025, achieving return on tangible equity of 11.3% with profit before tax rising 13% to £9.1bn and earnings per share up 22% to 43.8p...
Centrica Plc

Centrica raises over £80m from sale of non-core energy solutions assets

Centrica has announced the completion of multiple disposals across its energy solutions portfolio, generating total proceeds in excess of £80 million...
Vodafone Group

Vodafone Egypt secures additional 1,800MHz spectrum

Vodafone Egypt has acquired additional 1,800MHz spectrum as part of a government-led investment programme covering multiple frequency bands...
NatWest Group Plc

NatWest Group agrees £2.7bn acquisition of Evelyn Partners

NatWest Group has reached an agreement to acquire Evelyn Partners from funds advised by Permira and Warburg Pincus...
GSK

GSK receives EU approval for Nucala in Eosinophilic COPD

GSK plc announced that the European Commission has approved Nucala (mepolizumab) as an add-on maintenance treatment for adults with uncontrolled COPD characterised by raised blood eosinophils...
Vodafone Group

Vodafone delivers strong Q3 FY26 performance and reaffirms FY26 guidance

In Q3 FY26, Vodafone achieved strong service revenue growth across Europe and Africa, with continued momentum in Germany and Africa and good progress on the UK merger integration...
Shell plc

Shell plc Q4 2025 results reflect lower earnings and higher gearing

Shell plc’s unaudited fourth quarter 2025 results showed lower adjusted earnings and cash flow compared with the prior quarter, while full-year performance benefited from higher volumes, cost reductions and favourable tax movements despite lower commodity prices...
SSE Plc

SSE Plc Q3 Trading Update: EPS Guidance Maintained

SSE plc reports strong Q3 performance for the nine months to 31 December 2025, with a 64% increase in regulated networks investment and renewable output up 7% year on year...
GSK

GSK reports strong 2025 results and reaffirms long-term growth outlook

GSK delivered a strong financial performance in 2025, with sales of £32.7 billion driven by double-digit growth in Specialty Medicines across Respiratory, Immunology & Inflammation, Oncology and HIV...
DCC Energy

DCC Plc reports strong Q3 growth and maintains FY outlook

DCC plc reported strong adjusted operating profit growth in the third quarter ended 31 December 2025, driven by good organic performance and the first contribution from recent acquisitions...
Kingfisher plc

Kingfisher appoints Stephen Daintith as Non-Executive Director

Kingfisher plc has announced the appointment of Stephen Daintith to its Board as a Non-Executive Director and member of the Audit and Nomination Committees, effective 1 April 2026...
AstraZeneca

AstraZeneca Plc begins trading on the New York Stock Exchange

AstraZeneca has started trading its ordinary shares on the NYSE for the first time, aligning its listings across New York, London and Stockholm under a harmonised structure...
AstraZeneca

AstraZeneca signs $1.2bn obesity drug collaboration with CSPC

Under a new agreement with CSPC Pharmaceuticals, AstraZeneca will advance eight programmes targeting obesity and weight-related conditions, initially progressing four assets through Phase I...
Lloyds Banking Group

Lloyds reports strong 2025 performance and higher returns outlook

Lloyds Banking Group plc delivered a robust financial performance in 2025, with statutory profit before tax rising to £6.7 billion and return on tangible equity reaching 12.9%, or 14.8% excluding one-off charges...
3i Group Plc

3i Group FY2026 Q3 performance update: NAV growth driven by Action

3i Group reported a strong third quarter for FY2026, with NAV per share rising to 3,017 pence at 31 December 2025 and a total return of 20% for the nine months...
St. James's Place PLC

St. James’s Place reports record £220bn funds under management for 2025

St. James’s Place plc reported gross inflows of £21.9 billion for the year ended 31 December 2025, up 19% year on year, with net inflows rising 42% to £6.2 billion...

News and Interview Alerts

Subscribe Free

Company Presentations

Q&As

Hardman & Co

Green News

View all Sustainable sectors, Plcs and news >>  

Search

Search

Latest Interviews

BrokerTalk

Funds

View all Funds, Market Insights and news >> 

FTSE 100 News

UK Broker Ratings

Industrials

Severn Trent

Severn Trent on track for environmental targets and record capital investment year

Severn Trent Plc says trading for the period to 10 February 2026 is in line with expectations, with strong operational momentum and capital investment expected at the top end of its £1.7–£1.9 billion guidance...
BT Group Plc

BT Group confirms CEO changes across Openreach and BT International

From 1 April 2026, Katie Milligan will assume the role of CEO of Openreach, with Clive Selley moving to lead BT International...
AstraZeneca

AstraZeneca Q4 and FY 2025: Strong sales growth and pipeline momentum

Excerpt In FY 2025, AstraZeneca achieved 9% reported revenue growth and a 45% increase in reported EPS, reflecting strong commercial execution and pipeline progress...
Coca Cola

Coca-Cola HBC AG reports strong 2025 results with 8.1% organic revenue growth

Coca-Cola HBC AG delivered strong growth in 2025, with organic revenue up 8.1% and organic EBIT up 11.5%, driven by volume growth in Sparkling and Energy, disciplined revenue growth management, and continued investment in digital and AI capabilities...

Barclays reports double-digit returns across all divisions in 2025

Barclays PLC delivered a strong financial performance in 2025, achieving return on tangible equity of 11.3% with profit before tax rising 13% to £9.1bn and earnings per share up 22% to 43.8p...
Centrica Plc

Centrica raises over £80m from sale of non-core energy solutions assets

Centrica has announced the completion of multiple disposals across its energy solutions portfolio, generating total proceeds in excess of £80 million...
Vodafone Group

Vodafone Egypt secures additional 1,800MHz spectrum

Vodafone Egypt has acquired additional 1,800MHz spectrum as part of a government-led investment programme covering multiple frequency bands...
NatWest Group Plc

NatWest Group agrees £2.7bn acquisition of Evelyn Partners

NatWest Group has reached an agreement to acquire Evelyn Partners from funds advised by Permira and Warburg Pincus...
GSK

GSK receives EU approval for Nucala in Eosinophilic COPD

GSK plc announced that the European Commission has approved Nucala (mepolizumab) as an add-on maintenance treatment for adults with uncontrolled COPD characterised by raised blood eosinophils...
Vodafone Group

Vodafone delivers strong Q3 FY26 performance and reaffirms FY26 guidance

In Q3 FY26, Vodafone achieved strong service revenue growth across Europe and Africa, with continued momentum in Germany and Africa and good progress on the UK merger integration...
Shell plc

Shell plc Q4 2025 results reflect lower earnings and higher gearing

Shell plc’s unaudited fourth quarter 2025 results showed lower adjusted earnings and cash flow compared with the prior quarter, while full-year performance benefited from higher volumes, cost reductions and favourable tax movements despite lower commodity prices...
SSE Plc

SSE Plc Q3 Trading Update: EPS Guidance Maintained

SSE plc reports strong Q3 performance for the nine months to 31 December 2025, with a 64% increase in regulated networks investment and renewable output up 7% year on year...
GSK

GSK reports strong 2025 results and reaffirms long-term growth outlook

GSK delivered a strong financial performance in 2025, with sales of £32.7 billion driven by double-digit growth in Specialty Medicines across Respiratory, Immunology & Inflammation, Oncology and HIV...
DCC Energy

DCC Plc reports strong Q3 growth and maintains FY outlook

DCC plc reported strong adjusted operating profit growth in the third quarter ended 31 December 2025, driven by good organic performance and the first contribution from recent acquisitions...
Kingfisher plc

Kingfisher appoints Stephen Daintith as Non-Executive Director

Kingfisher plc has announced the appointment of Stephen Daintith to its Board as a Non-Executive Director and member of the Audit and Nomination Committees, effective 1 April 2026...
AstraZeneca

AstraZeneca Plc begins trading on the New York Stock Exchange

AstraZeneca has started trading its ordinary shares on the NYSE for the first time, aligning its listings across New York, London and Stockholm under a harmonised structure...
AstraZeneca

AstraZeneca signs $1.2bn obesity drug collaboration with CSPC

Under a new agreement with CSPC Pharmaceuticals, AstraZeneca will advance eight programmes targeting obesity and weight-related conditions, initially progressing four assets through Phase I...
Lloyds Banking Group

Lloyds reports strong 2025 performance and higher returns outlook

Lloyds Banking Group plc delivered a robust financial performance in 2025, with statutory profit before tax rising to £6.7 billion and return on tangible equity reaching 12.9%, or 14.8% excluding one-off charges...
3i Group Plc

3i Group FY2026 Q3 performance update: NAV growth driven by Action

3i Group reported a strong third quarter for FY2026, with NAV per share rising to 3,017 pence at 31 December 2025 and a total return of 20% for the nine months...
St. James's Place PLC

St. James’s Place reports record £220bn funds under management for 2025

St. James’s Place plc reported gross inflows of £21.9 billion for the year ended 31 December 2025, up 19% year on year, with net inflows rising 42% to £6.2 billion...
Load More

News and Interview Alerts

Subscribe Free

Company Presentations

Q&As

Hardman & Co

Green News

View all Sustainable sectors, Plcs and news >>  

Search

Search

Latest interviews

Broker Talk

Funds

View all Funds, Market Insights and news >> 

FTSE 100 News

UK Broker Ratings

FTSE 100

Latest Interviews

FTSE 100 News

FTSE 250 News

News and Interview Alerts

Subscribe Free

Company Presentations

Q&As

Hardman & Co

BrokerTalk

FTSE 100

Funds

View all Funds, Market Insights and news >> 

Green News

View all Sustainable sectors, Plcs and news >>  

UK Broker Ratings

Follow us on Social Media:

Home X-twitter Linkedin Facebook Spotify Apple